Moreover, enhancing antitumor activity was possible by combining FAP-specific CAR-T cells with T cells targeting cancer cells themselves, suggesting the benefit of co-targeting both CAFs and cancer cells in solid tumors. This evidence concerns the gene FAP and cancer.